Janet Ahern
About Janet Ahern
Janet Ahern is a clinical research professional with extensive experience in oncology and hematology, specializing in Electronic Data Capture systems and Good Clinical Practice. She has held significant roles at Celgene, Merck & Co., Sorrento Therapeutics, and currently at Kite Pharma.
Work at Kite Pharma
Janet Ahern has been working at Kite Pharma since 2020 in the role of Clinical Research. In this position, she focuses on advancing clinical trials and research initiatives within the organization. Kite Pharma is known for its innovative work in cell therapy, particularly in the treatment of cancer. Ahern's expertise in clinical research contributes to the company's mission of developing transformative therapies for patients.
Previous Experience at Celgene
From 2008 to 2018, Janet Ahern served as Senior Director of Hematology/Oncology Clinical Research & Development at Celgene Corporation. During her tenure, she played a significant role in overseeing clinical trials and research projects aimed at improving treatment options for hematological malignancies and solid tumors. Her leadership in this capacity contributed to the development of key therapies in oncology.
Experience at Merck & Co., Inc.
Janet Ahern worked at Merck & Co., Inc. in various capacities from 1985 to 2008. Initially, she served as a research biochemist for 19 years, followed by a role as Senior Clinical Research Specialist for 4 years. Her experience at Merck provided her with a solid foundation in clinical research methodologies and regulatory compliance, which are essential in the pharmaceutical industry.
Expertise in Electronic Data Capture Systems
Janet Ahern possesses expertise in Electronic Data Capture (EDC) systems, which are vital for the efficient management of clinical trial data. Her knowledge in this area enhances the accuracy and reliability of data collection and analysis in clinical research settings. This skill is particularly important for ensuring that clinical trials adhere to regulatory standards and produce valid results.
Background in Good Clinical Practice
Ahern has specialized skills in Good Clinical Practice (GCP), which ensures compliance with ethical and scientific quality standards in clinical trials. Her understanding of GCP is crucial for maintaining the integrity of clinical research and safeguarding the rights and well-being of trial participants. This background supports her work across various organizations in the pharmaceutical sector.